Adolescent Asthma Study

Ages Eligible for Study: Ages 12-21
Sexes Eligible for Study: All
  The VECTOR Study is a clinical research study for those with moderate to severe asthma, looking at flu vaccination alongside treatment with an investigational asthma drug. Approximately 100 participants are expected to take part in the USA. To qualify for the VECTOR Study, you must:
  • be aged 12-21 years
  • have experienced moderate to severe asthma for at least one year
  • be eligible for the seasonal flu vaccine.
There are other criteria that you will need to meet to qualify, which the study team will discuss with you. For further information about the VECTOR Study, contact our study team  by emailing tatiana@staampresearch.com or calling 210-851-8560 Apply Now: https://tinyurl.com/staampresearch  

100 doses of Johnson & Johnson COVID-19 vaccine administered to SAISD faculty, staff members

STAAMP Allergy administered the vaccines Tuesday morning

This story was originally published by KSAT12 and can be found here.  

100 SAISD employees vaccinated against COVID-19, kicking off local effort to immunize school staff

District leaders said they hope to have employees vaccinated by the end of May.

This story was originally published by Kens5 and can be found here.
SAN ANTONIO — More than 4.5 million Texans have received at least one dose of the coronavirus vaccine, and due to a recent announcement by the Biden administration, teachers and other school staff are now eligible to be immunized.
Those efforts are underway this week, as San Antonio ISD partnered with South Texas Allergy and Asthma Professionals (STAAMP) to vaccinate 100 employees on Tuesday.
Michael Rodriguez in an electrician with the district and was one of the dozens who received a prick in his arm.
“It’s very important so that I don’t get sick and I don’t infect others,” Rodriguez said.
Rodriguez said his days consist of traveling to different campuses and coming in contact with many different people.
“We’re around kids, teachers, and we just want to make sure everyone is safe and healthy,” he said.
The vaccines made up the first shipment of the Johnson & Johnson vaccine that STAAMP has received.
“We're happy to be able to have that service for them to help protect our some of our true first line heroes that are out there,” said Erika Gonzalez, CEO and president of STAAMP.
Gonzalez said the Johnson & Johnson vaccine – which consists of just one dose, unlike the Pfizer and Moderna options – has a 100% protection rate from death, according to studies.
“That’s really what the point is here, to save lives,” Gonzalez said. “The Johnson & Johnson (vaccine) is just as good as the other two vaccines. So, to the teachers out there – not just from the SAISD district, but from everywhere – we are thankful for you guys being out there, putting your lives on the line.”
SAISD Superintendent Pedro Martinez said the district has around 40% of students receiving in-classroom instruction.
“We know that we need more,” said Martinez. “We have many children that are remote right now, that are struggling, and parents are worried. So is our staff.”
The district partnered with Community Labs a few months ago to administer rapid COVID-19 testing to students and staff.
“We're one of the few districts in the country that offers that to our students and our staff, and that really reduces the anxiety," Martinez said. "What scares them the most is the unknown."
Martinez said the partnership with STAAMP marks the beginning of the effort to get local teachers, school staff and child care workers vaccinated.
He said around 25% of district staff has already received their vaccine.
The 100 employees who received the vaccine on Tuesday work at high schools, because many are still working doing extra-curricular activities and other events.
They also selected support and maintenance staff like Rodriguez who are continuing duties through Spring Break.
“We're going to be planning with STAAMP and other partners to try to get all of our staff done,” said Martinez.  “My hope is that we get them done by no later than mid-May.”
As for Rodriguez, he hopes his colleagues will get their vaccine when it’s available to them.
“It’s better to be safe than sorry, and we’ve already seen what sorry means,” he said.  “(There's) so many that we’ve lost already.”

SAISD realiza la vacunación contra el coronavirus de maestros y personal escolar

This story was originally published by Univision - KWEX 41 and can be found here. Cien maestros y empleados del distrito recibieron este martes la vacuna contra el coronavirus de la empresa Johnson & Johnson. Estas personas fueron seleccionadas ya que trabajarán durante el periodo de ‘spring break’.

San Antonio clinic seeks approval for remdesivir to be used outside of hospital

Study could help provide vital information to researchers as they develop COVID-19 treatment

This story was originally published by KSAT12 and can be found here

San Antonio Report board welcomes new chairman in new year

https://sanantonioreport.org/san-antonio-report-board-welcomes-new-chairman-in-new-year/ This story was originally published by San Antonio Report and can be found here
The turning of the calendar brought a turn in leadership to the San Antonio Report’s board of directors. A.J. Rodriguez ascended to board chairman late last month, after John “Chico” Newman Jr. stepped down from that position and the board after more than five years. The changes went into effect at the board’s Jan. 25 meeting. Rodriguez joined the board in 2020, after briefly serving on the San Antonio Report’s Board of Community Advisors. Founding Vice Chair Newman, who served as chairman for a year, decided to retire from the board because he believes the organization needs a fresh set of eyes. Newman served on the board since its inception, when the San Antonio Report, founded in 2012, reorganized as a nonprofit in 2016. The change in board leadership comes three months after the board named Angie Mock publisher and CEO of the nonprofit news organization, replacing co-founder Robert Rivard, who continues to serve as editor and lead columnist. Mock previously served as CEO of the Boys & Girls Club of San Antonio and had been a member of the San Antonio Report’s board since 2018. “We are deeply grateful for Chico’s vision, dedication, and passion that led us from a blog to a thriving nonprofit news organization,” Mock said. “Equally, I’m excited about what the future holds with A.J.’s leadership. A.J. brings a wealth of nonprofit success and strategic vision to the San Antonio Report.” Rodriguez joined the nonprofit Texas 2036 in September 2020 as the executive vice president. Texas 2036 is a nonpartisan organization that provides research-based solutions to make Texas a better place for all residents by the state’s bicentennial. Before that, he served as vice president of external affairs and on the executive leadership team of Zachry Group, a privately held construction and engineering business. Rodriguez also served as the deputy city manager for the City of San Antonio from 2008 to 2011. This experience makes Rodriguez the best fit to lead the board of directors as the San Antonio Report continues to evolve, Newman said. “He is the right person at the right time,” Newman said. “You really can’t be any better than the leadership of an organization. With the combination of Angie and A.J., the San Antonio Report has outstanding leadership.” A longtime fan of the San Antonio Report, Rodriguez said he joined the Board of Community Advisors and then the board of directors because he truly believes in the organization’s mission. “I’ve felt compelled to participate in any way I could to support the mission of the organization,” he said. Retired SBC Southwestern Bell President Wayne Alexander is the vice chair and treasurer of the board, while San Antonio Report founder and Editor Rivard serves as secretary. Other board directors include Teach for America Chief People Officer Laura Saldivar Luna, attorney Brian Steward, former Rackspace Community Affairs Director Cara Nichols, and Dr. Erika Gonzalez, CEO, president, and co-founder of South Texas Allergy and Asthma Professionals. Kate Rogers, a longtime H-E-B executive and the former vice president of community outreach and engagement for the Charles Butt Foundation, rounds out the eight-member board. As the new board chairman, Rodriguez said he wants to serve as a resource for the organization, to help grow and develop the San Antonio Report at “an increasingly rapid rate,” and to maintain the high standards of journalism it upholds. He also said he is excited to work with Mock as she carries the organization forward under her leadership. “There’s nowhere to go but up,” Rodriguez said. Looking back over the past five years, Newman said he could not agree more. If someone had told him five years ago that the San Antonio Report would be where it is today, he would have said that was “aspirational.” “For a small group, we punch way above our weight,” he said. Newman has watched the organization evolve from just a handful of people to a staff of 20, from a small startup to a professional organization. He said the shifts in leadership are part of the same evolution for the San Antonio Report and will help further its mission to build a more informed community. “We should constantly be learning, evolving, and getting better – and we have,” he said. “The organization has come a long way in five and a half years.”
San Antonio Report Staff

SAN ANTONIO REPORT STAFF

This article was assembled by various members of the San Antonio Report staff. 

Remdesevir Study

Ages Eligible for Study: Child, Adult, Older Adult
Sexes Eligible for Study: All
  STAAMP Research will begin an outpatient treatment opportunity trial offering Remdesevir, a prodrug, to patients who have tested positive for the novel COVID-19 disease. This trial is free to the patients that participate and helps provide vital information to researchers as they continue to develop a treatment for current and emerging strains of the virus. An earlier study of the Remdesevir drug has shown that patients that receive the medication recovered up to four days faster than those patients who had not. Treatment intervention in the earlier phase of COVID-19 in an outpatient setting may prevent disease progression leading to hospitalization that would benefit patients and could reduce the burden on the healthcare system.  
1 2 3 7